Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by dimar66on Mar 19, 2009 1:34am
410 Views
Post# 15854353

Notes from invest NW

Notes from invest NWRoche - Starting to sell cardio tests this month in N. America and will begin marketing in 8 Asian countries in the 2nd half of this year.  Other markets world wide in 2010, 2011.

3M - RSV - clinical work complete and submission for 510k review in April, aiming to have clearance for Fall 2009.

Shionogi - BNP, Japan only and the single channel reader

New opportunities are being investigated, cancer, coagulation, gynecological, and kidney and in discussion with multiple diagnostic players

Potential production capacity greater than 15million assorted tests a year would be about $100 million a year in revenue.

New facility has passed FDA QSIT audit inspection late last Aug

Cash Burn - reduced from $1.3 million to less than $0.7 million per month, cash should last through June 09 seeking alternative financing including debt financing
Bullboard Posts